Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification
Mercoledì 16 febbraio 2022
circa 1 minuti di lettura
Journal and Affiliations:
PLos One, 16 febbraio 2022
Marco Valgimigli, Cardiocentro Ticino, Lugano
Tags:
cardiovascular clinical trials
P2Y12 inhibitor
percutaneous coronary intervention
Authors:
Marco Valgimigli